UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 48,781 shares of the company’s stock, valued at approximately $223,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BNP Paribas Financial Markets acquired a new position in Aveanna Healthcare during the 4th quarter worth $35,000. KLP Kapitalforvaltning AS bought a new stake in shares of Aveanna Healthcare during the fourth quarter valued at about $35,000. Tower Research Capital LLC TRC lifted its holdings in Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock worth $36,000 after purchasing an additional 6,854 shares during the period. Catalyst Funds Management Pty Ltd grew its position in Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock valued at $54,000 after buying an additional 9,000 shares in the last quarter. Finally, Sagespring Wealth Partners LLC bought a new position in Aveanna Healthcare in the 4th quarter valued at about $57,000. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Stock Down 3.2%

NASDAQ:AVAH opened at $5.08 on Friday. The business’s 50-day moving average price is $5.09 and its 200 day moving average price is $4.92. Aveanna Healthcare Holdings Inc. has a 52-week low of $2.32 and a 52-week high of $6.19. The firm has a market cap of $991.08 million, a P/E ratio of -14.94 and a beta of 2.03.

Insider Buying and Selling at Aveanna Healthcare

In other news, CAO Deborah Stewart sold 15,457 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $5.56, for a total transaction of $85,940.92. Following the completion of the sale, the chief accounting officer now owns 285,396 shares in the company, valued at approximately $1,586,801.76. This represents a 5.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the business’s stock in a transaction on Tuesday, April 1st. The stock was sold at an average price of $5.63, for a total value of $31,415.40. Following the sale, the insider now directly owns 1,451,598 shares in the company, valued at $8,172,496.74. This trade represents a 0.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 7,164,257 shares of company stock valued at $38,118,993. 7.80% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have commented on the stock. UBS Group boosted their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a “sell” rating in a research report on Friday, May 9th. Truist Financial dropped their target price on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a report on Friday, April 11th.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.